1. Home
  2. TGLS vs OGN Comparison

TGLS vs OGN Comparison

Compare TGLS & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tecnoglass Inc.

TGLS

Tecnoglass Inc.

HOLD

Current Price

$37.67

Market Cap

1.6B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

SELL

Current Price

$13.77

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TGLS
OGN
Founded
1984
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
TGLS
OGN
Price
$37.67
$13.77
Analyst Decision
Buy
Hold
Analyst Count
4
5
Target Price
★ $55.75
$11.25
AVG Volume (30 Days)
333.1K
★ 2.0M
Earning Date
11-05-2026
11-09-2026
Dividend Yield
★ 1.63%
0.58%
EPS Growth
★ N/A
N/A
EPS
★ 1.27
0.95
Revenue
$370,984,000.00
★ $6,216,000,000.00
Revenue This Year
$12.44
N/A
Revenue Next Year
$11.39
$2.51
P/E Ratio
$28.95
★ $14.46
Revenue Growth
★ 17.98
N/A
52 Week Low
$34.05
$5.69
52 Week High
$63.46
$13.83

Technical Indicators

Market Signals
Indicator
TGLS
OGN
Relative Strength Index (RSI) 51.76 56.01
Support Level $37.43 $13.46
Resistance Level $46.99 $13.77
Average True Range (ATR) 1.34 0.04
MACD 0.43 0.00
Stochastic Oscillator 78.08 50.00

Price Performance

Historical Comparison
TGLS
OGN

About TGLS Tecnoglass Inc.

Tecnoglass Holdings Inc, formerly Tecnoglass Inc, is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: